These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 2737765)

  • 1. [Filtering effectiveness of conventional 15 m micron filters (DIN 58362) and newly developed 15 m micron and 5 m micron filters. I: Particle count].
    Walpot H; Franke RP; Burchard WG; Agternkamp C; Müller FG; Mittermayer C; Kalff G
    Infusionstherapie; 1989 Apr; 16(2):77-80. PubMed ID: 2737765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The filter effectiveness of common 15-micron filters (DIN 58362). II: Scanning electron microscopy and roentgen analysis].
    Walpot H; Franke RP; Burchard WG; Agternkamp C; Müller FG; Mittermayer C; Kalff G
    Infusionstherapie; 1989 Jun; 16(3):133-9. PubMed ID: 2503453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Particulate contamination of infusion solutions and drug additives within the scope of long-term intensive therapy. 1. Energy dispersion electron images in the scanning electron microscope-REM/EDX].
    Walpot H; Franke RP; Burchard WG; Agternkamp C; Müller FG; Mittermayer C; Kalff G
    Anaesthesist; 1989 Oct; 38(10):544-8. PubMed ID: 2511778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Microfilters within the scope of infusion therapy--possibilities and problems in retention of microbial and particle contaminants].
    Bach A; Böttiger BW
    Zentralbl Chir; 1994; 119(4):268-75. PubMed ID: 8203178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of microfilters within the scope of infusion therapy].
    Böttiger BW; Bach A
    Infusionsther Transfusionsmed; 1994 Feb; 21(1):42-51. PubMed ID: 8173311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Quantitative analysis of particulate matter in infusion solutions, administration sets and additives (author's transl)].
    Ahnefeld FW; Klaus E
    Anaesthesist; 1977 Aug; 26(8):476-84. PubMed ID: 907081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Particulate matter in four reconstituted cephalosporin injections.
    Kilarski DJ; Visconti JA; Frank SG
    Am J Hosp Pharm; 1983 Apr; 40(4):619-23. PubMed ID: 6846372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of particulate contamination in crystalloid cardioplegic solutions: studies by scanning and transmission electron microscopy.
    Hellinger A; Piotrowski J; Konerding MA; Burchard WG; Doetsch N; Peitgen K; Erhard J; Reidemeister JC
    Thorac Cardiovasc Surg; 1997 Feb; 45(1):20-6. PubMed ID: 9089970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silting index determination--an alternative to particle counting for the control of particulate contamination in infusion fluids.
    Ernerot L
    Acta Pharm Suec; 1974 Feb; 11(1):15-24. PubMed ID: 4816412
    [No Abstract]   [Full Text] [Related]  

  • 10. Final in-line filtration: removal of contaminants from IV fluids and drugs.
    Rapp RP; Bivins BA
    Hosp Formul; 1983 Dec; 18(12):1124-8. PubMed ID: 10264358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In line final filters for removing particles from amphotericin B infusions.
    Huber RC; Riffkin C
    Am J Hosp Pharm; 1975 Feb; 32(2):173-6. PubMed ID: 237416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous in-line filters: filtering the evidence.
    Ball PA
    Curr Opin Clin Nutr Metab Care; 2003 May; 6(3):319-25. PubMed ID: 12690266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Particulate-matter content of 11 cephalosporin injections: conformance with USP limits.
    Parkins DA; Taylor AJ
    Am J Hosp Pharm; 1987 May; 44(5):1111-8. PubMed ID: 3605122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of factors influencing ampoule secondary particulate contamination. A strategy for its reduction in small volume parenterals.
    Bernuzzi M; Raggi P; Montanari L
    Boll Chim Farm; 1991 Sep; 130(8):323-8. PubMed ID: 1801862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Particulate contamination of infusion solutions and drug additives in the framework of long-term intensive therapy. 2. An animal model].
    Walpot H; Franke RP; Burchard WG; Agternkamp C; Müller FG; Mittermayer C; Kalff G
    Anaesthesist; 1989 Nov; 38(11):617-21. PubMed ID: 2635837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Particulate matter test in small volume parenterals: critical aspects in sampling methodology.
    Pavanetto F; Conti B; Genta I; Ponci R; Montanari L; Grassi M
    Farmaco; 1989 Jun; 44(6):633-43. PubMed ID: 2803449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleanliness assessment of supplier-cleaned stoppers.
    Townsend MW; Conti B; Hazrati A; DeLuca PP
    J Parenter Sci Technol; 1989; 43(2):98-102. PubMed ID: 2709242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro use of epidural filters for prevention of bacterial infection.
    Kaushal M; Narayan S; Aggarwal A; Kapil A; Deorari AK
    Indian Pediatr; 2004 Nov; 41(11):1133-7. PubMed ID: 15591663
    [No Abstract]   [Full Text] [Related]  

  • 19. Contamination control in nursing with filtration. Part 1: filters applied to intravenous fluids and point-of-use hospital water.
    Ortolano GA; Russell RL; Angelbeck JA; Schaffer J; Wenz B
    J Infus Nurs; 2004; 27(2):89-103. PubMed ID: 15085036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Particulate contamination in parenterals: current issues.
    Groves MJ
    Boll Chim Farm; 1991 Oct; 130(9):347-54. PubMed ID: 1799429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.